Ativo Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,615
| Closed | -$965K | – | 52 |
|
|
2024
Q3 | $965K | Sell |
23,615
-149
| -0.6% | -$6.09K | 0.84% | 49 |
|
|
2024
Q2 | $915K | Sell |
23,764
-200
| -0.8% | -$7.7K | 0.95% | 45 |
|
|
2024
Q1 | $1.03M | Buy |
23,964
+98
| +0.4% | +$4.2K | 1.03% | 44 |
|
|
2023
Q4 | $884K | Sell |
23,866
-197
| -0.8% | -$7.3K | 0.94% | 46 |
|
|
2023
Q3 | $872K | Sell |
24,063
-202
| -0.8% | -$7.32K | 0.99% | 44 |
|
|
2023
Q2 | $865K | Sell |
24,265
-1,117
| -4% | -$39.8K | 0.91% | 45 |
|
|
2023
Q1 | $903K | Buy |
25,382
+2,801
| +12% | +$99.7K | 1.11% | 41 |
|
|
2022
Q4 | $793K | Sell |
22,581
-1,200
| -5% | -$42.2K | 1% | 49 |
|
|
2022
Q3 | $700K | Buy |
23,781
+11
| +0% | +$324 | 1.1% | 46 |
|
|
2022
Q2 | $1.29M | Sell |
23,770
-4,400
| -16% | -$239K | 0.87% | 36 |
|
|
2022
Q1 | $1.53M | Buy |
28,170
+74
| +0.3% | +$4.03K | 0.79% | 51 |
|
|
2021
Q4 | $1.55M | Sell |
28,096
-482
| -2% | -$26.6K | 0.69% | 72 |
|
|
2021
Q3 | $1.37M | Buy |
28,578
+2,946
| +11% | +$141K | 0.64% | 71 |
|
|
2021
Q2 | $1.28M | Sell |
25,632
-1,589
| -6% | -$79.1K | 0.54% | 89 |
|
|
2021
Q1 | $1.21M | Buy |
27,221
+1
| +0% | +$45 | 0.52% | 81 |
|
|
2020
Q4 | $1.25M | Buy |
27,220
+3,686
| +16% | +$170K | 0.54% | 70 |
|
|
2020
Q3 | $1.11M | Buy |
23,534
+16,400
| +230% | +$771K | 0.53% | 72 |
|
|
2020
Q2 | $364K | Buy |
+7,134
| New | +$364K | 0.2% | 98 |
|